Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective stud (Q41728053)
Jump to navigation
Jump to search
scientific article published on 23 September 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective stud |
scientific article published on 23 September 2014 |
Statements
Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study (English)
Joseph M Connors
Julie M Vose
Jeremy S Abramson
Silvia Montoto
Jérémy Brühlmann
Paula Y Tanaka
Kate Cwynarski
Samir Dalia
Michael Furman
Minh-Ly Nguyen
Timothy P Cooley
Jaime A Collins
HIV-Associated Hodgkin Lymphoma in the cART Era Study Group
Hansjakob Furrer
23 September 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference